Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens.
D000818:Animals; D000951:Antigens, Neoplasm; D001667:Binding, Competitive; D002860:Chromium Radioisotopes; D000242:Cyclic AMP / Q000032:analysis; D003601:Cytotoxicity Tests, Immunologic; D006632:Histamine / Q000378:metabolism* / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007111:Immunity, Cellular / Q000187:drug effects; D007114:Immunization; D007519:Isoantigens; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D011955:Receptors, Drug; D013601:T-Lymphocytes / Q000032:analysis / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D013890:Thiourea / Q000494:pharmacology
D000951:Antigens, Neoplasm; D002860:Chromium Radioisotopes; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D007519:Isoantigens; D011955:Receptors, Drug; D006632:Histamine; D000242:Cyclic AMP; D013890:Thiourea